Rheumatology Providers, FDA Leaders Discuss Biosimilar Policy Challenges and Opportunities at National Policy Briefing
20 juin 2016 18h41 HE
|
American College of Rheumatology
WASHINGTON, June 20, 2016 (GLOBE NEWSWIRE) -- Experts from the American College of Rheumatology (ACR), Food and Drug Administration (FDA), and other leading national healthcare groups spoke about the...
American College of Rheumatology Rolls Out Lupus Education for Providers & Patients in more than 25 States Nationwide
28 oct. 2015 10h20 HE
|
American College of Rheumatology
ATLANTA, Oct. 28, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) has awarded the American College of Rheumatology's (ACR) The Lupus Initiative (TLI) with a five-year...
![Levolta Pharmaceuticals, Inc. logo](/news-release/logo/316057/0/316057.jpg?lastModified=12%2F10%2F2016%2022%3A06%3A53&size=2)
Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting
18 nov. 2014 11h00 HE
|
Levolta Pharmaceuticals, Inc.
BETHLEHEM, Pa., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Levolta Pharmaceuticals, Inc. today presented the results of an exploratory Phase II study for a potential disease modifying drug for patients with...
The Lupus Initiative Unveils Free Curriculum and Education Materials to Advance Care for Patients Fighting Devastating Autoimmune Disease
16 mai 2013 10h50 HE
|
American College of Rheumatology
WASHINGTON, May 16, 2013 (GLOBE NEWSWIRE) -- The Lupus Initiative, a national provider education program led by the American College of Rheumatology, today announced a new easy-to-use curriculum and...